.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Teva
Argus Health
Accenture
Federal Trade Commission
Boehringer Ingelheim
Chinese Patent Office
Covington
Citi
Baxter

Generated: September 25, 2017

DrugPatentWatch Database Preview

CYCLOBENZAPRINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Cyclobenzaprine Hydrochloride, and what generic Cyclobenzaprine Hydrochloride alternatives are available?

Cyclobenzaprine Hydrochloride is a drug marketed by Oxford Pharms, Actavis Labs Fl Inc, Orit Labs Llc, Pliva, Sun Pharm Inds Ltd, Watson Labs, Frontida Biopharm, Aurobindo Pharma, Mylan Pharms Inc, Kvk Tech, Upsher-smith Labs, Jubilant Cadista, Rubicon Res Pvt Ltd, Invagen Pharms, Twi Pharms Inc, Sandoz, and Prinston Inc. and is included in eighteen NDAs.

The generic ingredient in CYCLOBENZAPRINE HYDROCHLORIDE is cyclobenzaprine hydrochloride. There are fifteen drug master file entries for this compound. Seventy-seven suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.

Summary for Tradename: CYCLOBENZAPRINE HYDROCHLORIDE

Patents:0
Applicants:17
NDAs:18
Suppliers / Packagers: see list75
Bulk Api Vendors: see list50
Clinical Trials: see list2,297
Patent Applications: see list700
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CYCLOBENZAPRINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: CYCLOBENZAPRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL090478-002Jul 23, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Rubicon Res Pvt Ltd
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL208170-001May 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Twi Pharms Inc
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL091281-001Jan 31, 2013DISCNNoNo► Subscribe► Subscribe► Subscribe
Rubicon Res Pvt Ltd
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL208170-002May 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Oxford Pharms
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL077209-002Feb 3, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL073144-002Feb 3, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL072854-001Nov 19, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Orit Labs Llc
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL078218-001Apr 18, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Prinston Inc
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL077797-001Feb 28, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL071611-003Feb 3, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Healthtrust
Argus Health
Johnson and Johnson
Federal Trade Commission
McKinsey
Express Scripts
Boehringer Ingelheim
Deloitte
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot